NCT02169323View on ClinicalTrials.gov

Step-down of Inhaled Corticosteroids (ICS) in Non-eosinophilic Asthmatics

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 27, 2017

Study Completion Date

February 27, 2017

Conditions
Asthma
Interventions
OTHER

Step-down

Step-down of the inhaled corticosteroid (ICS) dose until discontinuation for 6 months

Trial Locations (1)

4000

University Hospital of Liege, Liège

All Listed Sponsors
lead

Renaud Louis

OTHER

NCT02169323 - Step-down of Inhaled Corticosteroids (ICS) in Non-eosinophilic Asthmatics | Biotech Hunter | Biotech Hunter